Navigation Links
IMRIS announces development program for MR guided radiation and interventional applications

WINNIPEG, Feb. 19 /PRNewswire-FirstCall/ - IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") today announced a five-year research initiative to focus on the development and commercialization of MR-guided radiation therapy and interventional procedures, working with the University Health Network (UHN) in Toronto.

The collaboration signals the entry of IMRIS into the field of image guided radiation therapy, expanding on its existing expertise in neurosurgery. IMRIS, a market leader in the field of advanced surgical MR imaging and UHN, with its specialized knowledge in imaging and radiation therapy, will focus on the creation of innovative technologies for radiation therapy. The clinical setting for research and testing of technologies will be Princess Margaret Hospital (PMH), UHN's world-leading cancer research hospital. The IMRIS 3T movable MR will be installed at PMH to enable the development of new approaches to radiation therapy using active MR guidance.

The goals of the collaboration include the development of new technologies, the establishment of clinical workflows and the validation of the benefits of MR guided radiation therapy technology to both the patient and the health system. Planned applications include the integration of the IMRIS technology with external beam radiation therapy, MR guided biopsies and brachytherapy of the prostate.

Dr. David Jaffray, Head of Radiation Physics at PMH, said: "MR is a powerful, non-invasive imaging modality that enables us to better target disease and avoid healthy tissues. This is the future of cancer treatment and we're hoping that working with IMRIS will take us there faster."

"We are extremely pleased to be working with a recognized leader in cancer treatment and research," said David Graves President and CEO of IMRIS. "This co-development agreement represents a tremendous opportunity and opens an entirely new application for the existing IMRIS platform used in Neurosurgery today."

About Princess Margaret Hospital:

Princess Margaret Hospital has achieved an international reputation as a global leader in the fight against cancer and is considered one of the top comprehensive cancer treatment and research centres in the world. Located in Toronto, Canada, PMH is the only facility in Canada devoted exclusively to cancer research, treatment and education.

About IMRIS:

IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced surgical imaging solutions. The company's flagship product, IMRISneuro, utilizes patented technology that allows a high field MRI scanner to be moved in to the operating room on demand, providing imaging during the surgical procedure without compromising patient safety. This unique and innovative system has been validated by leading surgeons for use in world-class neuroscience centers.

For more information, visit

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IMRIS announces first IMRISneuro project in Australia
2. IMRISneuro: The iMRI technology of choice among the worlds top ranked hospitals
3. IMRISneuro at Central DuPage Hospital will be the first in the Chicago area
4. Dell Childrens Medical Center to install IMRISneuro in expanded neurocenter
5. Senior GE Executive to lead IMRIS Sales team in the U.S.
6. University of Virginia Health System invests in IMRISneuro, the next generation of surgical imaging technology
7. Providence St. Vincent bringing IMRISneuro, the worlds most advanced surgical MRI to Portland, Oregon
8. NuVasive Announces Web Cast and Conference Call of Fourth Quarter 2008 Results
9. Webcast Alert: Usinas Siderurgicas de Minas Gerais S.A. - USIMINAS Announces Fourth Quarter 2008 Earnings Results Webcast
10. PepsiCo Foundation Announces Grant to Save the Children to Address Malnutrition in Developing Nations
11. P&M Corporate Finance Announces Acquisition of Spine Technology Summit, Partners with Robin Young to Present 2009 Conference in Canary Wharf London
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology: